Infectious Diseases (except HIV/AIDS)
-
Describing COVID-19 Patients During The First Two Months of Paxlovid (Nirmatrelvir/Ritonavir) Initiation in a Large HMO in Israel
This article has 6 authors:Reviewed by ScreenIT
-
Immunogenicity and safety of the CoronaVac inactivated SARS-CoV-2 vaccine in people with underlying medical conditions: a retrospective study
This article has 16 authors:Reviewed by ScreenIT
-
Outcomes of convalescent plasma with defined high- versus lower-neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus Inactivating Plasma (CoVIP), double-blind phase 2 study
This article has 21 authors:Reviewed by ScreenIT
-
Epidemiological and clinical features of SARS‐CoV‐2 infection in children during the outbreak of Omicron variant in Shanghai, March 7–31, 2022
This article has 14 authors:Reviewed by ScreenIT
-
Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa
This article has 96 authors:Reviewed by ScreenIT
-
Omicron infection induces low-level, narrow-range SARS-CoV-2 neutralizing activity
This article has 10 authors:Reviewed by ScreenIT
-
Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals
This article has 5 authors:Reviewed by ScreenIT
-
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
This article has 35 authors:Reviewed by ScreenIT
-
A methodology to generate epidemic scenarios for emerging infectious diseases based on the use of key calendar events
This article has 5 authors:Reviewed by ScreenIT
-
Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination
This article has 18 authors:Reviewed by ScreenIT